Sign in
4

Changes in Ownership

PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001140361-15-045407

Chief Technology Officer acquired 120,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
WACHTER ERIC PHD Chief Technology Officer 2015-12-21 Option exercise +120,000 $1.02 $122,400 5,513,236 D
Derivatives
WACHTER ERIC PHD Chief Technology Officer 2015-12-21 Option exercise · Employee Stock Option (right to buy) −120,000 120,000 D
Loading xslF345X03/doc1.xml…